Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide long-term safety in primary generalized tonic-clonic seizures (EP0012)
CTR20170056Phase 3Completed
- Sponsor
- UCB
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lacosamide in idiopathic epilepsy (IGE), primary generalized tonic-clonic seizure (PGTCS), sponsored by UCB. Started Dec 2017; status: completed.
02
Drugs
lacosamide
03
Conditions
idiopathic epilepsy (IGE)primary generalized tonic-clonic seizure (PGTCS)
Beyond the preview
Go deeper on CTR20170056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170056.